Showing results (261-270 of 556) with videos related to
Sort By:
Pageof 56
Diabetes Care|March 29, 2003
Menstrual cycle differences between women with type 1 diabetes and women without diabetesElsa S Strotmeyer, Ann R Steenkiste, Thomas P Foley, et al.Journal of Capillary Electrophoresis and Microchip Technology|April 21, 2001
Determination of avoparcin in animal formulations by capillary electrophoresisC Lucas, M J Gliddon, M M Safarpour, et al.Journal of Thrombosis and Haemostasis : JTH|October 1, 2008
Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery diseaseA J Peace, A F Tedesco, D P Foley, et al.Experientia|May 15, 1991
The role of motile aeromonads in the fish disease, ulcerative disease syndrome (UDS)D J McGarey, L Milanesi, D P Foley, et al.Neuropeptides|October 1, 1992
The presence of neuropeptides in GABAergic and cholinergic rat cerebrocortical synaptosome sub-populationsP Foley, P D Hughes, H F Bradford, et al.International Journal of Cardiovascular Interventions|March 8, 2003
Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary interventionPascal Vranckx, David P Foley, Pim J de Feijter, et al.European Heart Journal|April 2, 2002
Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcomeR T van Domburg, D P Foley, A Breeman, et al.The EMBO Journal|March 14, 1998
Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiationK P Foley, G A McArthur, C Quéva, et al.Herz|February 1, 1992
Restenosis after percutaneous transluminal coronary angioplastyD P Foley, W M Hermans, B J Rensing, et al.The American Journal of Cardiology|May 26, 1994
Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study GroupD P Foley, H Bonnier, G Jackson, et al.Pageof 56